About Index Trending news
Analyze
Top 50 Pricing
Kerecis

Kerecis

Work at Kerecis? Add yourself to this profile

Kerecis

Kerecis is a developer of patent-pending MariGen™, an omega3 fish-skin acellular dermal matrix transplantation technology.

Elsewhere

Alexa global traffic share

Latest funding
Venture capital (Series A)
$2,000,000
Seed fund
Employees

Team size

10+

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Kerecis makes some noise.